The U.S. government's “Operation Warp Speed” aims to deliver a coronavirus vaccine to Americans by the end of the year, drawing on top minds in pharma, government and academia to do it. And now it has an experienced Big Pharma executive leading the charge.
The Trump administration has tapped former GlaxoSmithKline vaccine head Moncef Slaoui to lead the project, which incorporates the Department of Health and Human Services, the Department of Defense and other agencies to advance promising vaccines against COVID-19…
…Slaoui had a nearly 30-year run at GSK, joining in 1988 and leaving in 2017. He was a director for more than 10 years and also served as R&D head during his time at the drugmaker.
Slaoui has been a director of MRNA, but he resigned from that position today to avoid a conflict of interest insofar as MRNA is one of the companies involved with the Warp Speed project.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”